Delivery Order SPE2DR25D3103-SPE2DR26F9R98
Award Date 12/22/25
Potential Completion Date 1/14/26
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 11, 2025. This non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,248.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors on December 5, 2025, with completion targeted for December 29, 2025. This competitively awarded contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta (belimumab) is a biologic immunosuppressant used to treat systemic lupus erythematosus, representing...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus, representing a specialty...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Benlysta 200 mg/mL auto-injector units. This competitively awarded, non-set-aside contract carries a ceiling value of $6,165.34 and is scheduled for completion by July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Benlysta (belimumab) is a biologic immunosuppressant used to...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Benlysta 200 mg/ml auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of January 2, 2026, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Benlysta 200 mg/ml auto-injector with a ceiling value of $9,248.01. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order is scheduled for completion by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Benlysta (belimumab) is a biologic...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Benlysta (belimumab) is a monoclonal antibody used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $4,987.78 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on May 27, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta (belimumab) is a biologic medication used in the treatment of systemic lupus erythematosus and other...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 2, 2025, with completion expected by December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. Benlysta is a biologic medication used to treat systemic lupus erythematosus, and this award represents a specific product delivery under the...